Nadler Financial Group’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PTCT
CFM
PFC
BC
LSERS
SOADOR
ETC
Nadler Financial Group's PTCT Position: Q2 2026 in Review
Nadler Financial Group held its PTC Therapeutics (PTCT) position steady in Q2 2026 at 4,939 shares worth $403K. The position accounts for 0.03% of the portfolio, ranked #99.
Nadler Financial Group first reported a position in PTCT in Q3 2019 and has held it in 21 quarters since. 95 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Nadler Financial Group held 4,939 shares of PTC Therapeutics worth $403K as of Q2 2026.
- Nadler Financial Group left its PTC Therapeutics share count unchanged in Q2 2026.
- PTC Therapeutics made up 0.03% of Nadler Financial Group's portfolio in Q2 2026, its #99 holding.
- Nadler Financial Group first reported a position in PTC Therapeutics in Q3 2019 and has held it in 21 quarters since.
- 95 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Nadler Financial Group's 13F filing for Q2 2026, filed 30 Jul 2026.